Eight Years Follow-up After Rush Specific Oral Tolerance Induction to Cows Milk Proteins

Mariana Couto, Angela Gaspar, Cristina Santa-Marta, Mario Morais-Almeida


Cows milk allergy (CMA) has a great impact on children and families quality of life. Recent studies point to a tendency for longer duration and greater severity. Specific oral tolerance induction (SOTI) to cows milk (CM) has been regarded as a promising strategy to improve care of these patients, but prospective data concerning tolerance and safety after ending SOTI are still lacking. The longest follow-up reported had the duration of 4 years. We report a case of a young male, now aged 20 year-old, with persistent CMA, successfully submitted to a rush SOTI CM protocol, which kept CM tolerance after 8 years. During this time he maintained daily CM ingestion and strictly followed doctors instructions. With a faster and easier to perform protocol we achieved the same efficacy as those reported before. The key to success could be the regular exposition to allergen. Publishing these case reports reinforces the safety and efficacy of SOTI therapeutic strategy.

J Med Cases. 2012;3(1):31-33
doi: https://doi.org/10.4021/jmc400w


Anaphylaxis; Cow

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.